Neuropathology of schizophrenia: A mini review

Neuropathology

Volumn 27, Issue 6, 2007, Pages 604-608

  Iritani, Shuji ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cytoarchitect; Morphometry; Network; Neurodevelopment; Schizophrenia

Indexed keywords

ALZHEIMER DISEASE; AUTOPSY; BRAIN REGION; COMPUTER ASSISTED TOMOGRAPHY; COMPUTER PROGRAM; COMPUTER SYSTEM; CONFERENCE PAPER; DEGENERATIVE DISEASE; FRONTAL LOBE; FUNCTIONAL DISEASE; HUMAN; IMMUNOHISTOLOGY; MICROSCOPY; MOLECULAR BIOLOGY; MORPHOMETRICS; NERVE CELL DIFFERENTIATION; NERVE CELL NETWORK; NEUROIMAGING; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SCHIZOPHRENIA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STATISTICAL ANALYSIS; TEMPORAL LOBE;

BRAIN; HUMANS; SCHIZOPHRENIA;

EID: 35748937612     PISSN: 09196544     EISSN: 14401789     Source Type: Journal    
DOI: 10.1111/j.1440-1789.2007.00798.x     Document Type: Conference Paper

References (48)

1. Alzheimer A. Beiträge zur Pathologischen Anatomie der Hirnrinde und zur anatomiscen Grundlage der Psychozen. Mschr Psychiat Neurol 1907 2 : 82 120.
2. Tatetsu S. A contribution of the morphological Background of Schizophrenia, with special reference to the findings in the telencephalon. Acta Neuropathol (Berl) 1960 3 : 558 571.
3. Bachneff SA. Positron emission tomography and magnetic resonance imaging: a review and a local circuit neurons hypo (dys) function hypothesis of schizophrenia. Biol Psychiatry 1991 30 : 857 886.
4. Buchsbaum MS, Ingvar DH, Kessler R et al. Cerebral glucography with positron tomography. Use in normal subjects and in patients with schizophrenia. Arch Gen Psychiatry 1982 39 : 251 259.
5. Gunther W. MRI-SPECT and PET-EEG findings on brain dysfunction in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 1992 16 : 445 462.
6. Harrison PJ. The neuropathology of schizophrenia. A critical review of the data and their interpretation. Brain 1999 122 : 593 624.
7. Lawrie SM, Abukmeil SS, Chiswick A et al. Qualitative cerebral morphology in schizophrenia: a magnetic resonance imaging study and systematic literature review. Schizophr Res 1997 25 : 155 166.
8. Lieberman J, Bogerts B, Degreef G et al. Qualitative assessment of brain morphology in acute and chronic schizophrenia. Am J Psychiatry 1992 149 : 784 794.
9. Bogerts B, Meertz E, Schonfeldt-Bausch R. Basal ganglia and limbic system pathology in schizophrenia. A morphometric study of brain volume and shrinkage. Arch Gen Psychiatry 1985 42 : 784 791.
10. Falkai P, Bogerts B. Cell loss in the hippocampus of schizophrenics. Eur Arch Psychiatry Neurol Sci 1986 236 : 154 161.
11. Jeste DV, Lohr JB. Hippocampal pathologic findings in schizophrenia. A morphometric study. Arch Gen Psychiatry 1989 46 : 1019 1024.
12. Zaidel DW, Esiri MM, Harrison PJ. Size, shape, and orientation of neurons in the left and right hippocampus: investigation of normal asymmetries and alterations in schizophrenia. Am J Psychiatry 1997 154 : 812 818.
13. Arnold SE, Hyman BT, Van Hoesen GW, Damasio AR. Some cytoarchitectural abnormalities of the entorhinal cortex in schizophrenia. Arch Gen Psychiatry 1991 48 : 625 632.
14. Altshuler LL, Conrad A, Kovelman JA, Scheibel A. Hippocampal pyramidal cell orientation in schizophrenia. A controlled neurohistologic study of the Yakovlev collection. Arch Gen Psychiatry 1987 44 : 1094 1098.
15. Akbarian S, Vinuela A, Kim JJ et al. Distorted distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase neurons in temporal lobe of schizophrenics implies anomalous cortical development. Arch Gen Psychiatry 1993 50 : 178 187.
16. Bogerts B. The neuropathology of schizophrenic diseases: historical aspects and present knowledge. Eur Arch Psychiatry Clin Neurosci 1999 249 (Suppl 4 2 13.
17. Casanova MF, Rothberg B. Shape distortion of the hippocampus: a possible explanation of the pyramidal cell disarray reported in schizophrenia. Schizophr Res 2002 55 : 19 24.
18. Jakob H, Beckmann H. Circumscribed malformation and nerve cell alterations in the entorhinal cortex of schizophrenics. Pathogenetic and clinical aspects. J Neural Transm Gen Sect 1994 98 : 83 106.
19. Beckmann H, Jakob H. Prenatal disturbances of nerve cell migration in the entorhinal region: a common vulnerability factor in functional psychoses? J Neural Transm Gen Sect 1991 84 : 155 164.
20. Benes FM, McSparren J, Bird ED, SanGiovanni JP, Vincent SL. Deficits in small interneurons in prefrontal and cingulate cortices of schizophrenic and schizoaffective patients. Arch Gen Psychiatry 1991 48 : 996 1001.
21. Rajkowska G, Selemon LD, Goldman-Rakic PS. Neuronal and glial somal size in the prefrontal cortex: a postmortem morphometric study of schizophrenia and Huntington disease. Arch Gen Psychiatry 1998 55 : 215 224.
22. Selemon LD, Rajkowska G, Goldman-Rakic PS. Abnormally high neuronal density in the schizophrenic cortex. A morphometric analysis of prefrontal area 9 and occipital area 17. Arch Gen Psychiatry 1995 52 : 805 818.
23. Weinberger DR. A connectionist approach to the prefrontal cortex. J Neuropsychiatry Clin Neurosci 1993 5 : 241 253.
24. Weinberger DR, Lipska BK. Cortical maldevelopment, anti-psychotic drugs, and schizophrenia: a search for common ground. Schizophr Res 1995 16 : 87 110.
25. Ikeda K, Ikeda K, Iritani S, Ueno H, Niizato K. Distribution of neuropeptide Y interneurons in the dorsal prefrontal cortex of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2004 28 : 379 383.
26. Niizato K, Iritani S, Ikeda K, Arai H. Astroglial function of schizophrenic brain: a study using lobotomized brain. Neuroreport 2001 12 : 1457 1460.
27. Iritani S, Kuroki N, Niizato K, Ikeda K. Morphological changes in neuropeptide Y-positive fiber in the hippocampal formation of schizophrenics. Prog Neuropsychopharmacol Biol Psychiatry 2000 24 : 241 249.
28. Iritani S, Kuroki N, Ikeda K, Kazamatsuri H. Calbindin immunoreactivity in the hippocampal formation and neocortex of schizophrenics. Prog Neuropsychopharmacol Biol Psychiatry 1999 23 : 409 421.
29. Niizato K, Arai T, Kuroki N et al. Autopsy study of Alzheimer's disease brain pathology in schizophrenia. Schizophr Res 1998 31 : 177 184.
30. Rapoport JL, Addington AM, Frangou S, Psych MR. The neurodevelopmental model of schizophrenia: update 2005. Mol Psychiatry 2005 10 : 434 449.
31. Glantz LA, Lewis DA. Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch Gen Psychiatry 2000 57 : 65 73.
32. Durany N, Thome J. Neurotrophic factors and the pathophysiology of schizophrenic psychoses. Eur Psychiatry 2004 19 : 326 337.
33. Iritani S, Niizato K, Nawa H, Ikeda K, Emson PC. Immunohistochemical study of brain-derived neurotrophic factor and its receptor, TrkB, in the hippocampal formation of schizophrenic brains. Prog Neuropsychopharmacol Biol Psychiatry 2003 27 : 801 807.
34. Bai O, Chlan-Fourney J, Bowen R, Keegan D, Li XM. Expression of brain-derived neurotrophic factor mRNA in rat hippocampus after treatment with antipsychotic drugs. J Neurosci Res 2003 71 : 127 131.
35. Harrison PJ, Weinberger DR. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry 2005 10 : 40 68.
36. Wassink TH, Nopoulos P, Pietila J, Crowe RR, Andreasen NC. NOTCH4 and the frontal lobe in schizophrenia. Am J Med Genet B Neuropsychiatr Genet 2003 118 : 1 7.
37. Ishizuka K, Paek M, Kamiya A, Sawa A. A review of Disrupted-In- Schizophrenia-1 (DISC1): neurodevelopment, cognition, and mental conditions. Biol Psychiatry 2006 59 : 1189 1197.
38. Ozeki Y, Tomoda T, Kleiderlein J et al. Disrupted-in-Schizophrenia-1 (DISC-1): mutant truncation prevents binding to NudE-like (NUDEL) and inhibits neurite outgrowth. Proc Natl Acad Sci USA 2003 100 : 289 294.
39. Kamiya A, Kubo K, Tomoda T et al. A schizophrenia-associated mutation of DISC1 perturbs cerebral cortex development. Nat Cell Biol 2005 7 : 1167 1178.
40. Talbot K, Eidem WL, Tinsley CL et al. Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hippocampal formation in schizophrenia. J Clin Invest 2004 113 : 1353 1363.
41. Numakawa T, Yagasaki Y, Ishimoto T et al. Evidence of novel neuronal functions of dysbindin, a susceptibility gene for schizophrenia. Hum Mol Genet 2004 13 : 2699 2708.
42. Hashimoto R, Straub RE, Weickert CS, Hyde TM, Kleinman JE, Weinberger DR. Expression analysis of neuregulin-1 in the dorsolateral prefrontal cortex in schizophrenia. Mol Psychiatry 2004 9 : 299 307.
43. Ohnishi T, Hashimoto R, Mori T et al. The association between the Val158Met polymorphism of the catechol-O-methyl transferase gene and morphological abnormalities of the brain in chronic schizophrenia. Brain 2006 129 : 399 410.
44. Mirnics K, Middleton FA, Stanwood GD, Lewis DA, Levitt P. Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia. Mol Psychiatry 2001 6 : 293 301.
45. Ho BC, Milev P, O'Leary DS, Librant A, Andreasen NC, Wassink TH. Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers. Arch Gen Psychiatry 2006 63 : 731 740.
46. Agartz I, Sedvall GC, Terenius L et al. BDNF gene variants and brain morphology in schizophrenia. Am J Med Genet B Neuropsychiatr Genet 2006 141 : 513 523.
47. Ashe PC, Berry MD, Boulton AA. Schizophrenia, a neurodegenerative disorder with neurodevelopmental antecedents. Prog Neuropsychopharmacol Biol Psychiatry 2001 25 : 691 707.
48. Jonsson EG, Edman-Ahlbom B, Sillen A et al. Brain-derived neurotrophic factor gene (BDNF) variants and schizophrenia: an association study. Prog Neuropsychopharmacol Biol Psychiatry 2006 30 : 924 933.